34 Results for "

norepinephrine release

" in MedChemExpress (MCE) Product Catalog:
Products (34)

34 Results for "norepinephrine release" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B1202
CAS No.: 51411-04-2
Synonyms: AY-22284
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Alrestatin (AY-22284) is an aldose reductase inhibitor. Alrestatin reduces fructose levels in the uterine fluid of mice. Alrestatin interferes with sperm capacitation and impairs fertilization function in mice. Alrestatin decreases basal and tyramine-induced norepinephrine release in rat pancreatic specimens in vitro. Alrestatin enhances glucose- and arginine-stimulated insulin secretion in vivo. Alrestatin can be used in studies related to diabetes and reproductive diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N3198A
CAS No.: 6882-66-2
Synonyms: (-)-Sophoramine
Sophoramine ((-)-Sophoramine) is a prejunctional α2-adrenoceptor inhibitor that can be found in the seeds of Sophora alopecuroides. Sophoramine inhibits prejunctional α2-adrenoceptors to facilitate norepinephrine release from adrenergic nerves. Sophoramine shows cytotoxic activity against human cancer cells, positive inotropic activity, and activity in rodent arrhythmia models. Sophoramine can be used for the research of arrhythmias .
loading...
    loading...
Cat. No.: HY-137683A
Synonyms: GDPβS trisodium
Target:  

Adenylate Cyclase

Research Areas:  

Cardiovascular Disease

Guanosine 5'-O-(2-thiodiphosphate) trisodium (GDPβS trisodium) is a non-hydrolyzable derivative of GDP. Guanosine 5'-O-(2-thiodiphosphate) trisodium acts as an inhibitor of adenylyl cyclase (AC) with a Ki value of 600 nM. In the absence of glutamic-pyruvic transaminase (GPT) in cerebral cortex membranes of rodent models, Guanosine 5'-O-(2-thiodiphosphate) trisodium partially activates AC with an EC50 of 400 nM. Guanosine 5'-O-(2-thiodiphosphate) trisodium prevents norepinephrine-induced nitric oxide release in ventricular myocytes .
loading...
    loading...
Cat. No.: HY-105856
CAS No.: 655-05-0
Purity:  99.93%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Thozalinone is an orally active antidepressant agent. Thozalinone induces the release of Norepinephrine (HY-13715) and dopamine .
loading...
    loading...
Cat. No.: HY-12716A
CAS No.: 681806-46-2
Purity:  ≥99.0%
BRL-44408 maleate is a selective, blood-brain barrier-permeable α2A-adrenergic receptor antagonist with a Ki value of 8.56 nM against human targets. BRL-44408 maleate exhibits activities such as antidepressant, analgesic effects and attenuation of sepsis-induced acute lung injury by regulating the release of neurotransmitters such as norepinephrine and dopamine, or inhibiting signaling pathways including ERK1/2, p38MAPK and p65. BRL-44408 maleate can be used in studies related to acute respiratory distress syndrome, depression and visceral pain .
loading...
    loading...
Cat. No.: HY-106865
CAS No.: 125472-02-8
Mivazerol is a selective α2-adrenoceptor agonist. Mivazerol decreases the spontaneous release of serotonin (5-HT) and significantly inhibits the immobilization stress-induced enhancement of norepinephrine (NE), dopamine (DA) and dihydroxyphenylacetic acid (DOPAC). Mivazerol inhibits intrathecal release of glutamate evoked by halothane withdrawal in rats, and exerts neuroprotective effects in forebrain ischemia rats. Mivazerol can be used for myocardial ischemia research .
loading...
    loading...
Cat. No.: HY-W685943
CAS No.: 372-66-7
Heptaminol is a fatty amine with pressor properties and a potential antihypotension agent. Heptaminol is also a competitive inhibitor of norepinephrine uptake and an inhibitor of nicotine-induced catecholamine release (IC50: 650 μM). Heptaminol does not inhibit norepinephrine release induced by 59 mM K + but rather inhibits high-affinity Na +-dependent norepinephrine uptake .
loading...
    loading...
Cat. No.: HY-18332C
CAS No.: 66504-40-3
DOV-216,303 (Free Base) is a potent triple serotonin, norepinephrine, and dopamine reuptake inhibitor, with IC50 values of 14 nM, 20 nM and 78 nM for hSERT, hNET and hDAT, respectively. Has antidepressant-like effects and increases monoamine release in the prefrontal cortex of olfactory bulbectomized (OBX) rats .
loading...
    loading...
Cat. No.: HY-16094
CAS No.: 114-85-2
Synonyms: BW 467C60
Bethanidine sulfate (BW 467C60) is an orally active antihypertensive agent and adrenergic neuron blocker. Bethanidine sulfate exerts its antihypertensive effect by inhibiting the release of norepinephrine from sympathetic nerve terminals. Bethanidine sulfate exhibits anti-ventricular arrhythmic activity. Bethanidine sulfate can be used in research related to hypertension, ventricular tachycardia, and ventricular fibrillation .
loading...
    loading...
Cat. No.: HY-118387
CAS No.: 498577-53-0
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

AVE-0118 is a Kv1.5 potassium channel blocker and antiarrhythmic agent. AVE-0118 blocks neuronal Kv1.5 potassium channels, thereby enhancing the release of norepinephrine. AVE-0118 enhances field stimulation-induced neurogenic contraction, an effect sensitive to α1-adrenergic receptor blockade. AVE-0118 terminates persistent atrial fibrillation in some dogs. AVE-0118 is applicable to research related to atrial fibrillation and persistent atrial fibrillation .
loading...
    loading...
Cat. No.: HY-12716
CAS No.: 118343-19-4
BRL-44408 is a selective, blood-brain barrier-permeable α2A-adrenergic receptor antagonist with a Ki value of 8.56 nM against human targets. BRL-44408 exhibits activities such as antidepressant, analgesic effects and attenuation of sepsis-induced acute lung injury by regulating the release of neurotransmitters such as norepinephrine and dopamine, or inhibiting signaling pathways including ERK1/2, p38MAPK and p65. BRL-44408 can be used in studies related to acute respiratory distress syndrome, depression and visceral pain .
loading...
    loading...
Cat. No.: HY-158552
CAS No.: 2446466-62-0
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

4-EEC hydrochloride is a synthetic stimulant substance. 4-EEC hydrochloride is a releasing agent for norepinephrine-dopamine .
loading...
    loading...
Cat. No.: HY-W722796
CAS No.: 6411-75-2
Target:  

Adrenergic Receptor

Research Areas:  

Others

Tuaminoheptane sulfate is an alpha-adrenergic receptor agonist. Tuaminoheptane sulfate exerts its decongestant and irritant effects by inhibiting norepinephrine reuptake and promoting its release. Tuaminoheptane sulfate can be used in research on nasal diseases such as decongestion .
loading...
    loading...
Cat. No.: HY-P11313
Synonyms: Rat chromogranin A367–387
Target:  

nAChR Akt

Research Areas:  

Cardiovascular Disease

Catestatin (rat) (Rat chromogranin A367–387) is a potent, reversible, noncompetitive, and noncooperative nicotinic cholinergic antagonist derived from chromogranin A (A367-387). Catestatin (rat) inhibits norepinephrine release in rat PC12 pheochromocytoma cells (IC50 = 1.2 μM), and blocks desensitization of norepinephrine release (IC50 = 0.62 μM). Catestatin (rat) exerts antiadrenergic effects through the endothelial PI3K-AKT-eNOS pathway in rat papillary muscles and isolated cardiomyocytes. Catestatin (rat) maintains mitochondrial membrane potential in I/R cardiomyocytes and increases phosphorylation of AKT at S473, GSK3β at S9, PLB at T17, and eNOS at S1179. Catestatin (rat) reverses desensitization of 22Na + uptake. Catestatin (rat) can be used for the study of nicotinic cholinergic receptor regulation and catecholamine release control mechanisms .
loading...
    loading...
Cat. No.: HY-106504
CAS No.: 86696-87-9
Target:  

Imidazoline Receptor

Research Areas:  

Neurological Disease

Aganodine is a guanidine that activates presynaptic imidazoline receptors and can inhibit electrically evoked [ 3H]-norepinephrine release .
loading...
    loading...
Cat. No.: HY-115762
CAS No.: 55206-11-6
Purity:  97.94%
4-Hydroxytryptamine creatinine sulfate, a tryptamine derivative, is a neurotransmitter agonist .
loading...
    loading...
Cat. No.: HY-W922811
CAS No.: 19772-76-0
Target:  

iGluR

Research Areas:  

Neurological Disease

DL-Willardiine is an AMPA antagonist with an IC50 of 2 μM. DL-Willardiine can be utilized in psychotropic cccccc research .
loading...
    loading...
Cat. No.: HY-14607
CAS No.: 130953-69-4
Synonyms: HP 749
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Besipirdine (hydrochloride) is a potassium channel blocker with cholinergic and adrenergic activity. The cholinergic activity of Besipirdine (hydrochloride) involves stimulating phosphatidylinositol turnover and reducing potassium currents. The adrenergic activity of Besipirdine (hydrochloride) involves stimulating norepinephrine release, which is attributed to the inhibition of presynaptic α2-adrenergic receptors and the inhibition of norepinephrine uptake. Besipirdine (hydrochloride) may be used in research for Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-W342779
CAS No.: 58400-88-7
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

4-Bromoamphetamine hydrochloride is an amphetamine derivative which acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA) and produces stimulant effects. 4-Bromoamphetamine hydrochloride is highly neurotoxic, producing long-term depletion of serotonin .
loading...
    loading...
Cat. No.: HY-129668
CAS No.: 75684-07-0
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

Bremazocine is a potent opioid kappa receptor agonist with analgesic activity. Bremazocine induces peripheral analgesia by releasing endogenous norepinephrine. The analgesic effect of bremazocine is associated with interaction with adenosine receptors. Bremazocine produces a dose-dependent peripheral analgesia after topical application. The effect of bremazocine is affected by nonselective α(2) adrenaline receptor antagonists, suggesting that it acts through a norepinephrine pathway .
loading...
    loading...